A detailed history of Axiom Investors LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Axiom Investors LLC holds 444,508 shares of AZN stock, worth $29.5 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares
444,508
Holding current value
$29.5 Million
% of portfolio
0.31%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$76.67 - $87.62 $34.1 Million - $38.9 Million
444,508 New
444,508 $34.6 Million
Q3 2023

Nov 13, 2023

SELL
$64.85 - $71.7 $59.8 Million - $66.1 Million
-921,989 Reduced 98.86%
10,600 $717,000
Q2 2023

Aug 10, 2023

BUY
$69.91 - $75.81 $3.17 Million - $3.44 Million
45,318 Added 5.11%
932,589 $66.7 Million
Q1 2023

May 12, 2023

SELL
$63.15 - $71.6 $115 Million - $130 Million
-1,821,139 Reduced 67.24%
887,271 $61.6 Million
Q4 2022

Feb 09, 2023

BUY
$54.21 - $70.44 $19.8 Million - $25.7 Million
365,550 Added 15.6%
2,708,410 $184 Million
Q3 2022

Nov 10, 2022

BUY
$53.02 - $135.75 $43.5 Million - $111 Million
820,354 Added 53.88%
2,342,860 $128 Million
Q2 2022

Aug 11, 2022

BUY
$59.26 - $71.14 $90.2 Million - $108 Million
1,522,506 New
1,522,506 $101 Million
Q4 2020

Feb 12, 2021

SELL
$48.52 - $58.02 $64.6 Million - $77.3 Million
-1,332,070 Closed
0 $0
Q3 2020

Nov 12, 2020

BUY
$53.07 - $61.1 $2.98 Million - $3.43 Million
56,150 Added 4.4%
1,332,070 $73 Million
Q2 2020

Aug 13, 2020

BUY
$43.1 - $55.31 $6.79 Million - $8.71 Million
157,450 Added 14.08%
1,275,920 $67.5 Million
Q1 2020

May 14, 2020

BUY
$37.79 - $51.33 $1.21 Million - $1.64 Million
31,890 Added 2.93%
1,118,470 $50 Million
Q4 2019

Feb 13, 2020

SELL
$42.46 - $50.46 $5.51 Million - $6.55 Million
-129,790 Reduced 10.67%
1,086,580 $54.2 Million
Q3 2019

Nov 13, 2019

BUY
$40.12 - $45.47 $8.37 Million - $9.49 Million
208,610 Added 20.7%
1,216,370 $54.2 Million
Q2 2019

Aug 07, 2019

BUY
$37.28 - $41.68 $8.88 Million - $9.93 Million
238,145 Added 30.94%
1,007,760 $41.6 Million
Q1 2019

May 13, 2019

SELL
$35.49 - $43.02 $15,970 - $19,359
-450 Reduced 0.06%
769,615 $31.1 Million
Q4 2018

Feb 14, 2019

BUY
$36.86 - $41.49 $28.4 Million - $31.9 Million
770,065 New
770,065 $29.2 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $205B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Axiom Investors LLC Portfolio

Follow Axiom Investors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Axiom Investors LLC , based on Form 13F filings with the SEC.

News

Stay updated on Axiom Investors LLC with notifications on news.